Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.

Chibon F, Lagarde P, Salas S, Pérot G, Brouste V, Tirode F, Lucchesi C, de Reynies A, Kauffmann A, Bui B, Terrier P, Bonvalot S, Le Cesne A, Vince-Ranchère D, Blay JY, Collin F, Guillou L, Leroux A, Coindre JM, Aurias A.

Nat Med. 2010 Jul;16(7):781-7. doi: 10.1038/nm.2174. Epub 2010 Jun 27.

PMID:
20581836
2.

RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.

Lesluyes T, Pérot G, Largeau MR, Brulard C, Lagarde P, Dapremont V, Lucchesi C, Neuville A, Terrier P, Vince-Ranchère D, Mendez-Lago M, Gut M, Gut I, Coindre JM, Chibon F.

Eur J Cancer. 2016 Apr;57:104-11. doi: 10.1016/j.ejca.2015.12.027. Epub 2016 Feb 23.

PMID:
26916546
3.

Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.

Lagarde P, Przybyl J, Brulard C, Pérot G, Pierron G, Delattre O, Sciot R, Wozniak A, Schöffski P, Terrier P, Neuville A, Coindre JM, Italiano A, Orbach D, Debiec-Rychter M, Chibon F.

J Clin Oncol. 2013 Feb 10;31(5):608-15. doi: 10.1200/JCO.2012.46.0147. Epub 2013 Jan 14.

PMID:
23319690
4.

[Grading of soft tissue and bone sarcomas].

Petersen I, Wardelmann E.

Pathologe. 2016 Jul;37(4):320-7. doi: 10.1007/s00292-016-0184-6. German.

PMID:
27384333
5.

Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors.

Lagarde P, Pérot G, Kauffmann A, Brulard C, Dapremont V, Hostein I, Neuville A, Wozniak A, Sciot R, Schöffski P, Aurias A, Coindre JM, Debiec-Rychter M, Chibon F.

Clin Cancer Res. 2012 Feb 1;18(3):826-38. doi: 10.1158/1078-0432.CCR-11-1610. Epub 2011 Dec 13.

6.

Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.

Hasegawa T, Yokoyama R, Lee YH, Shimoda T, Beppu Y, Hirohashi S.

Oncology. 2000;58(1):66-74.

PMID:
10644943
7.

Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.

Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C, Haie-Meder C, Duvillard P.

Cancer. 2000 Mar 15;88(6):1425-31.

PMID:
10717626
8.

Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.

Francis P, Namløs HM, Müller C, Edén P, Fernebro J, Berner JM, Bjerkehagen B, Akerman M, Bendahl PO, Isinger A, Rydholm A, Myklebost O, Nilbert M.

BMC Genomics. 2007 Mar 14;8:73.

9.

[Sarcoma gene signatures].

Chibon F, Coindre JM.

Pathologe. 2011 Feb;32(1):32-9. doi: 10.1007/s00292-010-1393-z. Review. German.

PMID:
21287318
10.

Histological grading and MIB-1 labeling index of soft-tissue sarcomas.

Hasegawa T.

Pathol Int. 2007 Mar;57(3):121-5. Review.

PMID:
17295643
11.

Grading of soft tissue sarcomas: from histological to molecular assessment.

Neuville A, Chibon F, Coindre JM.

Pathology. 2014 Feb;46(2):113-20. doi: 10.1097/PAT.0000000000000048. Review.

PMID:
24378389
12.

[Prediction of the metastatic potential of sarcomas on the basis of a gene expression signature related to genome complexity].

Chibon F.

Med Sci (Paris). 2011 Jan;27(1):22-4. doi: 10.1051/medsci/201127122. French. No abstract available.

14.

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.

Bertucci F, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G, Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J, Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D, Fert V, Birnbaum D, Viens P.

Breast Cancer Res Treat. 2011 Jun;127(2):363-73. doi: 10.1007/s10549-010-1003-z. Epub 2010 Jun 29.

PMID:
20585850
16.
17.

Sampling modality influences the predictive value of grading in adult soft tissue extremity sarcomas.

Khoja H, Griffin A, Dickson B, Wunder J, Ferguson P, Howarth D, Kandel R.

Arch Pathol Lab Med. 2013 Dec;137(12):1774-9. doi: 10.5858/arpa.2012-0427-OA.

PMID:
24283858
18.

Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas.

Wong P, Hui A, Su J, Yue S, Haibe-Kains B, Gokgoz N, Xu W, Bruce J, Williams J, Catton C, Wunder JS, Andrulis IL, Gladdy R, Dickson B, O'Sullivan B, Liu FF.

Oncotarget. 2015 Nov 17;6(36):39127-39. doi: 10.18632/oncotarget.3926.

19.

Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up.

Zelek L, Llombart-Cussac A, Terrier P, Pivot X, Guinebretiere JM, Le Pechoux C, Tursz T, Rochard F, Spielmann M, Le Cesne A.

J Clin Oncol. 2003 Jul 1;21(13):2583-8.

PMID:
12829679
20.

Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.

Przybyl J, Sciot R, Wozniak A, Schöffski P, Vanspauwen V, Samson I, Siedlecki JA, Rutkowski P, Debiec-Rychter M.

Int J Biochem Cell Biol. 2014 Aug;53:505-13. doi: 10.1016/j.biocel.2014.05.006. Epub 2014 May 16.

PMID:
24842110

Supplemental Content

Support Center